Cyrus Harmon
Founder bij OLEMA PHARMACEUTICALS, INC.
Vermogen: 11 M $ op 31-03-2024
Profiel
Cyrus L.
Harmon is the founder.
He founded Neomorphics, Inc. in 1996, where he served as the Chief Executive Officer from 1996 to 2000.
He also founded Olema Pharmaceuticals, Inc. in 2006 and currently holds the title of Director.
In addition to his founding positions, Dr. Harmon previously worked at Affymetrix, Inc. as the General Manager from 2000 to 2002.
Dr. Harmon obtained his undergraduate and doctorate degrees from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
28-03-2024 | 948 311 ( 1.70% ) | 11 M $ | 31-03-2024 |
Actieve functies van Cyrus Harmon
Bedrijven | Functie | Begin |
---|---|---|
OLEMA PHARMACEUTICALS, INC. | Founder | 07-08-2006 |
Eerdere bekende functies van Cyrus Harmon
Bedrijven | Functie | Einde |
---|---|---|
AFFYMETRIX, INC. | Corporate Officer/Principal | 01-01-2002 |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Chief Executive Officer | 01-01-2000 |
Opleiding van Cyrus Harmon
University of California, Berkeley | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OLEMA PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Health Technology |